Boston Globe reporter Hiawatha Bray spotlights Pison Technology, an MIT startup that has developed a new gesture control system that can be used to manipulate “digital devices by intercepting the electronic traffic between our hands and our brains, and translating them into commands the machines can understand.”
Writing for The New Yorker, Sheelah Kolhatkar spotlights Biobot Analytics, an MIT startup that is studying sewage for the purpose of tracking diseases and the spread of Covid-19. “It’s about our health and well-being in general,” says Biobot co-founder and president Newsha Ghaeli. “It’s about understanding nutrition disparities in communities, understanding stress levels, pervasive infectious diseases like influenza or Zika virus.”
New York Times reporter Steve Lohr spotlights Inrupt, an MIT startup founded by Prof. Tim Berners-Lee, which is aimed at providing people more control over their personal data. “Tim has become increasingly concerned as power in the digital world is weighted against the individual,” explains Daniel Weitzner, a principal research scientist at CSAIL.
TechCrunch reporter Jonathan Shieber spotlights Senti Biosciences, an MIT startup, which is developing cancer therapies using a new programmable biology platform. “The company’s technology uses new computational biological techniques to manufacture cell and gene therapies that can more precisely target specific cells in the body,” Shieber explains.
Fortune reporters Jeremy Kahn and Jonathan Vanian highlight MIT startup Macro-Eyes, which is focused on using AI to improve health care in low and middle-income countries.
In an article for The Boston Globe, Scott Kirsner spotlights Inrupt, an MIT startup that has developed new technology that “proposes a major change in how personal data are stored that would give you much more control.”
Boston Globe columnist Shirley Leung spotlights how the development of the Moderna Covid-19 vaccine demonstrates the success of the Massachusetts life sciences sector. “For more than half a century, the Massachusetts Institute of Technology has been the epicenter of that curiosity, with a focus on molecular biology — initially to find a cure for cancer,” writes Leung. “There have been Nobel laureates collaborating on cancer, genetics, and immunology, along with future laureates making discoveries in how RNA, a molecule that is as fundamental as DNA to cell function, can be used in medicine.”
Wall Street Journal reporter Paul Berger highlights Superpedestrian, an MIT startup and electric scooter company that secured $60 million in funding. Berger notes that Superpedestrian “spent more than four years designing a vehicle intelligence system that can diagnose and maintain itself.”
Forbes contributor Louis Columbus spotlights Verta, an MIT startup that is “dedicated to solving the complex problems of managing machine learning model versions and providing a platform where they can be launched into production.”
Fast Company reporter Elizabeth Segran spotlights the work of alumna Amanda Parkes, the chief innovation officer for Pangaia, which is focused on finding an alternative to plastic-based fibers.
Forbes contributor Rob Toews spotlights the work of Professor Daniela Rus, the deputy dean of research for the Schwarzman College of Computing and director of CSAIL; graduate student Joy Buolamwini; and former MIT postdoc Rana el Kaliouby for their work shaping the future of AI. “They also serve as role models for the next generation of AI leaders, reflecting what a more inclusive AI community can and should look like," writes Toews.
Forbes contributor Angelica Krystle Donati spotlights MIT startup Clockworks Analytics, which “leverages existing products installed in buildings such as thermostats, building automation devices, and other sensors and focuses on generating sophisticated analytics based on that data.”
PlateJoy, a company founded by MIT alumna Christina Bognet, “offers a sophisticated digital platform that helps take some of the guesswork, challenge and waste out of eating for better health,” writes Elaine Howley for U.S. News & World Report.
Fast Company reporter Adele Peters spotlights Particles for Humanity, an MIT spinoff that is developing a new technology that makes it possible to deliver multiple doses of a vaccine in one shot. “The new technology works like traditional drug delivery,” writes Peters, “but with the addition of tiny time-release capsules filled with antigens, the part of the vaccine that stimulates the immune system so that it can later respond to a virus.”
Financial Times reporter Henry Sanderson spotlights Prof. Donald Sadoway’s work developing new battery chemistries that would allow batteries to store energy for longer than six hours.